Maintenance therapy with oxytocin antagonists for inhibiting preterm birth after threatened preterm labour

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 10, 2013, Pages

  Papatsonis, Dimitri N M ^a   Flenady, Vicki ^b   Liley, Helen G ^c  

^a AMPHIA HOSPITAL   (Netherlands)

^b Translating Research Into Practice   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ATOSIBAN; PLACEBO; UTERUS SPASMOLYTIC AGENT; ARGIPRESTOCIN; DRUG DERIVATIVE; OXYTOCIN RECEPTOR;

DRUG EFFICACY; DRUG SAFETY; GESTATION PERIOD; HOSPITAL DISCHARGE; HUMAN; MAINTENANCE THERAPY; MULTICENTER STUDY (TOPIC); NEWBORN MORBIDITY; PERINATAL MORTALITY; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; UTERINE CERVIX DILATATION; DRUG ANTAGONISM; FEMALE; PREGNANCY; PREMATURITY; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; OBSTETRIC LABOR, PREMATURE; PREMATURE BIRTH;

FEMALE; HUMANS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREMATURE BIRTH; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, OXYTOCIN; TOCOLYTIC AGENTS; VASOTOCIN;

EID: 84899470465     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005938.pub3     Document Type: Review

References (30)

1. Gagnon D, Martens L, Creasy G, Henke C. An economic analysis of atosiban maintenance therapy in preterm labor. American Journal of Obstetrics and Gynecology 1998;178(1 Pt 2):S181.
2. Sanchez-Ramos L, Valenzuela G, Romero R, Silver H, Koltun W, Millar L, et al.Antocin PTL 098 Study Group. A double-blind placebo-controlled trial of oxytocin receptor antagonist (antocin) maintenance therapy in patients with preterm labor. American Journal of Obstetrics and Gynecology 1997;176(1Pt 2):S30.
3. Valenzuela G, Sanchez-Ramos L, Romero R, Silver HM, Koltun WD, Millar L, et al.Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group. American Journal of Obstetrics and Gynecology 2000;182(5):1184-90.
4. Anotayanonth S, Subhedar NV, Garner P, Neilson JP, Harigopal S. Betamimetics for inhibiting preterm labour. Cochrane Database of Systematic Reviews 2004, Issue 4. [DOI: 10.1002/14651858.CD004352.pub2]
5. Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, et al.National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012 Jun 9;379(9832):2162-72.
6. Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database of Systematic Reviews 2002, Issue 4. [DOI: 10.1002/14651858.CD001060]
7. Dodd JM, Crowther CA, Middleton P. Oral betamimetics for maintenance therapy after threatened preterm labour. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.CD003927.pub3]
8. Duckitt K, Thornton S. Nitric oxide donors for the treatment of preterm labour. Cochrane Database of Systematic Reviews 2002, Issue 3. [DOI: 10.1002/14651858.CD002860]
9. Gagnon D, Martens L, Creasy G, Henke C. An economic analysis of atosiban maintenance therapy in preterm labor. American Journal of Obstetrics and Gynecology 1998;178(1 Pt 2):S181.
10. Gaunekar NN, Crowther CA. Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour. Cochrane Database of Systematic Reviews 2004, Issue 3. [DOI: 10.1002/14651858.CD004071.pub2]
11. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008;5(371(9606)):75-84. [: 10.1016/S0140-6736(08)60074-4]
12. Gyetvai K, Hannah M, Hodnett E, Ohlsson A. Tocolysis for preterm labor: a systematic review. Obstetrics & Gynecology 1999;94(5):869-77.
13. Hack M, Fanaroff AA. Outcomes of children of extremely low birthweight and gestational age in the 1990's. Early Human Development 1999;53(3):193-218.
14. Han S, Crowther CA, Moore V. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour. Cochrane Database of Systematic Reviews 2013, Issue 5. [DOI: 10.1002/14651858.CD000940.pub3]
15. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org. The Cochrane Collaboration. Available from www.cochrane-handbook.org, 2008.
16. Khanprakob T, Laopaiboon M, Lumbiganon P, Sangkomkamhang US. Cyclo-oxygenase (COX) inhibitors for preventing preterm labour. Cochrane Database of Systematic Reviews 2012, Issue 10. [DOI: 10.1002/14651858.CD007748.pub2]
17. King JF, Grant A, Keirse MJNC, Chalmers I. Beta-mimetics in preterm labour: an overview of the randomized controlled trials. British Journal of Obstetrics and Gynaecology 1988;95:211-22.
18. King JF, Flenady VJ, Papatsonis DNM, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour. Cochrane Database of Systematic Reviews 2003, Issue 1. [DOI: 10.1002/14651858.CD002255]
19. Kramer MS. The epidemiology of adverse pregnancy outcomes: an overview. Journal of Nutrition 2003;133:1592S-1596S.
20. Lumley J. Defining the problem: the epidemiology of preterm birth. BJOG: an international journal of obstetrics and gynaecology 2003;110:3-7.
21. McCain GC, Deatrick JA. The experience of high-risk pregnancy. Journal of Obstetric, Gynecologic and Neonatal Nursing 1993;23:421-7.
22. Nanda K, Cook LA, Gallo MF, Grimes DA. Terbutaline pump maintenance therapy after threatened preterm labor for preventing preterm birth. Cochrane Database of Systematic Reviews 2002, Issue 4. [DOI: 10.1002/14651858.CD003933]
23. Papatsonis D, Flenady V, Cole S, Liley H. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD004452.pub2]
24. Petrou S, Eddama O, Mangham L. A structured review of the recent literature on the economic consequences of preterm birth. Archives of Disease in Childhood. Fetal and Neonatal Edition 2011 May;96(3):F225-32. [: 10.1136/adc.2009.161117. Epub 2010 May 20]
25. Powell SL, Holt VL, Hickok DE, Easterling T, Connell FA. Recent changes in delivery site of low-birth-weight infants in Washington: impact on birth weight-specific mortality. American Journal of Obstetrics and Gynecology 1995;173:1585-92.
26. The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copehagan: The Nordic Cochrane Centre: The Cochrane Collaboration, 2012.
27. Roberts D, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD004454.pub2]
28. Sanchez-Ramos L, Valenzuela G, Romero R, Silver H, Koltun W, Millar L, Wang J, Creasy G, Antocin PTL 098 Study Group. A double-blind placebo-controlled trial of oxytocin receptor antagonist (antocin) maintenance therapy in patients with preterm labor. American Journal of Obstetrics and Gynecology 1997;176(1 Pt 2):S30.
29. March of Dimes, PMNCH, Save the Children, WHO. In: Howson CP, Kinney MV, Lawn JE editor(s). Born Too Soon: The Global Action Report on Preterm Birth. Geneva: World Health Organization, 2012.
30. Papatsonis D, Flenady V, Liley H. Maintenance therapy with oxytocin antagonists for inhibiting preterm birth after threatened preterm labour. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD005938.pub2]